对特有甲素耐药黄金葡萄球菌的控制:在重症监护病房的成本效益分析
C Chaix1, I Durand-Zaleski, C Alberti
1Department of Public Health, Créteil, France.
JAMA
|November 24, 1999
概括
在特有重症监护病房 (ICU) 实施耐甲金色葡萄球菌 (MRSA) 控制计划,包括查和隔离,是具有成本效益的. 这一策略通过减少MRSA感染和相关的医疗保健成本,提供了显著的好处.
科学领域:
- 传染性疾病 传染性疾病
- 医院流行病学 医院流行病学
- 卫生经济学 卫生经济学
背景情况:
- 地方性甲素耐药黄金葡萄球菌 (MRSA) 在医院中构成了挑战.
- 由于担心成本和效益有限,阻碍了MRSA控制计划的实施.
研究的目的:
- 为了比较MRSA控制计划在流行性医院环境中的经济成本和收益.
- 评估MRSA携带者选择性查和隔离的成本效益.
主要方法:
- 在法国一所大学医院的医疗重症监护室 (ICU) 进行了一项病例控制研究.
- 将MRSA感染的成本与控制计划 (查和隔离) 的成本进行了比较.
- 敏感性分析探讨了各种传染率,感染率和停留时间.
主要成果:
- 感染MRSA的平均成本为9275美元,而控制计划的成本从每名患者的340美元到1480美元不等.
- 在MRSA感染率下降14%使得控制计划具有好处.
- 这种策略对MRSA携带流行率占主导地位,在ICU入院时为1%至7%.
结论:
- 选择性查和MRSA携带者在ICU入院后的隔离在流行环境中是有益的.
- 这种方法比没有隔离策略更具成本效益.
- 这些发现支持在医院实施MRSA控制计划.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


